Find your next paid study

Robert G. Webster, MD, MPHNCT07852390

~$10 – $1,125

Actual pay is set by the research site.

The Fundamentals of Communication in Surgery (FCS): A Pilot Study to Evaluate the Scalability and Impact of A Clinical Communication Curriculum

The goal of this observational study is to evaluate the impact of the FCS curriculum on achieving the learning objectives and resident reported self-efficacy w…

Communication ResearchCommunication Programs

University of Wisconsin, MadisonNCT06654310

Actual pay is set by the research site.

Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more

Red Blood Cell Transfusion Threshold-Specific Bleeding, Quality of Life and Functional Outcomes in Acute Leukemia Patients With Thrombocytopenia: a Randomized Feasibility Study

This clinical trial evaluates the effects of hemoglobin threshold-specific packed red blood cell (PRBC) transfusions on quality of life and functional outcomes…

University of WashingtonNCT06710418

Actual pay is set by the research site.

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce ba…

StressAnxiety

Dana-Farber Cancer InstituteNCT06038318

~$10 – $1,125

Actual pay is set by the research site.

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy [SUpplemental Patient dMd assessMents Investigating ouTcomes (SUMMIT)]

The goal of this study is to collect additional information on the safety of long-term treatment with AGAMREE® and to explore long-term clinical impact of AGAM…

Duchenne Muscular Dystrophy

Catalyst Pharmaceuticals, Inc.NCT06564974

~$10 – $1,050

Actual pay is set by the research site.

Chronic Obstructive Lung Disease

A Phase 1b/2a, Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Activity of Small Mobile Stem Cells (SMS) Delivered Into the Lung as a Potential Organ Regeneration Therapy in Moderate to Severe Chronic Obstructive Pulmonary Disease (SORT-COPD Study II)

This study is a phase 1b/2a, open-label, non-randomized, observation of 125 adults, with moderate to severe chronic obstructive pulmonary disease, treated with…

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

~$150 – $4,200

Actual pay is set by the research site.

SMSbiotechNCT07871890

Phase 2

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (Tocilizumab) for the Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) J…

Nationwide Children's HospitalNCT05233397

~$75 – $2,000

Actual pay is set by the research site.

Long-COVIDPASCLong COVID Syndrome

Osteopathic Manipulative Therapy(OMT) Effects on Post-Acute Sequalae of COVID-19(PASC)

This study is investigating the effects of using an Osteopathic Manipulative Therapy (OMT) treatment protocol that was shown to statistically improve smell in …

University of LouisvilleNCT06883513

Actual pay is set by the research site.

PainDementia, MildDementia, Moderate

Caregiver-assisted Pain Coping Skills Training for Dementia Pilot Study

The purpose of the study is to develop a caregiver-assisted pain coping skills training program for older adults who have pain and mild to moderate dementia an…

Duke UniversityNCT06854718

Actual pay is set by the research site.

Chronic Graft Versus Host Disease

Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft Versus Host Disease

This is an open-label phase I study of fostamatinib in combination with ruxolitinib for the treatment of chronic GvHD with a suboptimal response to corticoster…

Stefanie Sarantopoulos, MD, PhD.NCT06233110

~$150 – $4,500

Actual pay is set by the research site.

Pancreatic Adenocarcinoma Metastatic

Phase 1b Dose Escalation Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast activation protein (FAP) antibody-drug conjugate (ADC), in combination with gemcitabine…

Oncomatryx Biopharma S.L.NCT07377045

~$150 – $4,200

Actual pay is set by the research site.

A Phase I First-in-human Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Antiviral Activity of the Broadly Neutralizing Antibody BNT351 in Adults Living Without and With HIV

This study will test the safety and blood levels of the antibody BNT351 in people living without and with human immunodeficiency virus (HIV). This study will a…

HIV -1 Infection